{
  "directed": true,
  "graph": {
    "annotation_curie": [],
    "annotation_list": {},
    "annotation_miriam": [],
    "annotation_pattern": {},
    "annotation_url": {
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert, Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Screening of a neuronal cell model of Tau pathology for therapeutic compounds",
      "version": "1.0.1"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc.genefamily-names.belns"
    },
    "path": "tau/pickhardt2018.bel",
    "pybel_version": "0.15.3"
  },
  "links": [
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "As shown before, Tau aggregation (on the level of oligomeric and/or fibril aggregates) is toxic for cells.",
      "key": "5c3d5a6b467ec4f4bee9f3215f47a7d7",
      "line": 79,
      "relation": "increases",
      "source": 0,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "The dose response screening identified compounds related to the inhibition of 3 major targets led to inhibition of Tau aggregation: p38 MAPK (7 out of 8 compounds in the initial library), VEGFR1/2 (3 of 8) and TGF (3 of 10). ",
      "key": "e32bd54df57a11de3aaaf61570a87c23",
      "line": 87,
      "relation": "increases",
      "source": 54,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "23a9d0726d3edc1f2af5a9269fe9c061",
      "line": 207,
      "relation": "association",
      "source": 54,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "09b1ee1ea48d2ccad347794dc98e79e7",
      "line": 208,
      "relation": "association",
      "source": 54,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "dc209f6ac0fc7f6fc67225839430db15",
      "line": 220,
      "relation": "association",
      "source": 54,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "The dose response screening identified compounds related to the inhibition of 3 major targets led to inhibition of Tau aggregation: p38 MAPK (7 out of 8 compounds in the initial library), VEGFR1/2 (3 of 8) and TGF (3 of 10). ",
      "key": "207d14b1224ae2a73dd1c796ac059822",
      "line": 88,
      "relation": "increases",
      "source": 44,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "The dose response screening identified compounds related to the inhibition of 3 major targets led to inhibition of Tau aggregation: p38 MAPK (7 out of 8 compounds in the initial library), VEGFR1/2 (3 of 8) and TGF (3 of 10). ",
      "key": "0b0acd40ab951b039fc6e96f167065ae",
      "line": 89,
      "relation": "increases",
      "source": 52,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "a90ea8ac3c137e0a713332d903332a8b",
      "line": 202,
      "relation": "association",
      "source": 52,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "07a37634a7b4e19d122f27681543e341",
      "line": 204,
      "relation": "association",
      "source": 52,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "The dose response screening identified compounds related to the inhibition of 3 major targets led to inhibition of Tau aggregation: p38 MAPK (7 out of 8 compounds in the initial library), VEGFR1/2 (3 of 8) and TGF (3 of 10). ",
      "key": "d452c2c983fcabeed760dd4f00edf3b0",
      "line": 90,
      "relation": "increases",
      "source": 39,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": " Conversely, compounds related to HDAC inhibition (16 of 20) led to enhanced Tau aggregation, suggesting that HDAC activity is important for suppressing aggregation",
      "key": "1c0f66913fa590f5d9b0210a59b60bbb",
      "line": 97,
      "relation": "decreases",
      "source": 36,
      "source_modifier": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "9bbba61505c2aa90a2d985d0438696a7",
      "line": 185,
      "relation": "association",
      "source": 36,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Treatment with Givinostat (1.2 µM) lead to a nearly 7-fold increase in the fraction of ThS + cells (from ~ 12% to ~ 84%, Fig. S4A and B, blue lines) compared to the uninduced control, and 2.5-fold compared to the induced control. ",
      "key": "1168047fd3b04438af75b93ee1a36260",
      "line": 106,
      "relation": "decreases",
      "source": 26,
      "target": 36,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Treatment with Givinostat (1.2 µM) lead to a nearly 7-fold increase in the fraction of ThS + cells (from ~ 12% to ~ 84%, Fig. S4A and B, blue lines) compared to the uninduced control, and 2.5-fold compared to the induced control. ",
      "key": "c6566b45b26e470ddbd98c441ce02bc8",
      "line": 107,
      "relation": "increases",
      "source": 26,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ddab25f532b1d0d64504a2ea358568e3",
      "line": 155,
      "relation": "increases",
      "source": 28,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "1833201aa2c033d7b3154054e3d33cd2",
      "line": 185,
      "relation": "association",
      "source": 28,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "29712ef25bcbb0b4b1093f5e20977037",
      "line": 156,
      "relation": "increases",
      "source": 11,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "d7971de18204e34808ae9a7a3a66cb2e",
      "line": 186,
      "relation": "association",
      "source": 11,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "736876cf261ddf74eeba8baaa4fc0c39",
      "line": 187,
      "relation": "association",
      "source": 11,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "82e369529cb5a863c35ad8b738300f19",
      "line": 157,
      "relation": "increases",
      "source": 8,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "804537002a44041a3899c60fea418625",
      "line": 188,
      "relation": "association",
      "source": 8,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "11e4b28a1224c3e5b01574a671bcebd4",
      "line": 189,
      "relation": "association",
      "source": 8,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "96b768bebf186036def75cf312d234e8",
      "line": 190,
      "relation": "association",
      "source": 8,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "8be87f4c69b8f2d1bba662dd787a73f7",
      "line": 191,
      "relation": "association",
      "source": 8,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "2e59db2049ec6a666c03c499e53901d0",
      "line": 158,
      "relation": "increases",
      "source": 14,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "d0ee4fef65b4b6a901e7ae1309825378",
      "line": 192,
      "relation": "association",
      "source": 14,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "915e4f4bf8dad2c11771bb9c2ad4fcf0",
      "line": 159,
      "relation": "increases",
      "source": 20,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "e82027b038e04a4f55f77bb33cdc1865",
      "line": 193,
      "relation": "association",
      "source": 20,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ed7ac569a56630f0a4c40c19115c14af",
      "line": 194,
      "relation": "association",
      "source": 20,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "f96080d471289b6de23a903b7b69f977",
      "line": 160,
      "relation": "increases",
      "source": 24,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "3577bcc45e57e31abd1a1c950c1261a9",
      "line": 195,
      "relation": "association",
      "source": 24,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ea0ee87a746b059aa59cee4630d43220",
      "line": 196,
      "relation": "association",
      "source": 24,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "9436f32be63503dede61e1992f5956e4",
      "line": 161,
      "relation": "increases",
      "source": 12,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "980bebd0297f195e10f4955410e81e09",
      "line": 197,
      "relation": "association",
      "source": 12,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "a606fc1fdf4adcbadcd29e94c74b1d3d",
      "line": 162,
      "relation": "increases",
      "source": 9,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "61b3793ab15f34ae85ea620c71ed5edc",
      "line": 198,
      "relation": "association",
      "source": 9,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "b908b75130298e7a6cc17b12b29146da",
      "line": 163,
      "relation": "increases",
      "source": 25,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "f7319fa623bd2c92310dd47a35bc0c18",
      "line": 199,
      "relation": "association",
      "source": 25,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "f441ed260d2873dbde28ec14b93ac748",
      "line": 164,
      "relation": "increases",
      "source": 21,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "585773c9f67b49e98660f2f845e27cbc",
      "line": 200,
      "relation": "association",
      "source": 21,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ad21f09f538dc570605591c7470d7698",
      "line": 166,
      "relation": "decreases",
      "source": 3,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ead3540e3109e9141ec8ee28ebc35fd3",
      "line": 202,
      "relation": "association",
      "source": 3,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "f793e5dccb9cdf4df5ed57124111fcc0",
      "line": 167,
      "relation": "decreases",
      "source": 15,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "1725c187cbb27695670ca00a6b5abd60",
      "line": 203,
      "relation": "association",
      "source": 15,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "55c716b460504d18c68c8910116d933b",
      "line": 168,
      "relation": "decreases",
      "source": 4,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "859d67406a3f47aeb2d706d4ca5d01b2",
      "line": 204,
      "relation": "association",
      "source": 4,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "15edd4d388f98ca1399f3c824ecf0709",
      "line": 169,
      "relation": "decreases",
      "source": 16,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "dc5dbdae978a884272b6770a8f1dd66d",
      "line": 205,
      "relation": "association",
      "source": 16,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "9030c16a4ab6f982847107d533dfe10d",
      "line": 170,
      "relation": "decreases",
      "source": 23,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "0c7390458ec2cfe5152bdd210fd4dd26",
      "line": 206,
      "relation": "increases",
      "source": 23,
      "target": 60,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ad7a88949ec8fbb131f54656251870b1",
      "line": 171,
      "relation": "decreases",
      "source": 5,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "3b127d3bda1e4841262b75e0a0ee773b",
      "line": 207,
      "relation": "association",
      "source": 5,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "3a912dea18cca3595ede9cbd50d3bc63",
      "line": 172,
      "relation": "decreases",
      "source": 7,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "cdf00e8bda923116662197ab8fa2a267",
      "line": 208,
      "relation": "association",
      "source": 7,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "c1650fc5218f85adb5ec2bb902ed8386",
      "line": 173,
      "relation": "decreases",
      "source": 29,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "d9f11f347bd516c6388ed8a3771e3bd5",
      "line": 209,
      "relation": "decreases",
      "source": 29,
      "target": 41,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "84394256c65f3a15f3061a9dee2b726b",
      "line": 174,
      "relation": "decreases",
      "source": 10,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "e28bd92faf0aaa2874e42368642a4ded",
      "line": 210,
      "relation": "association",
      "source": 10,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "30e9b20c0ebe4b55a317ee88341bcedd",
      "line": 175,
      "relation": "decreases",
      "source": 19,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "86b39a3d3125404a8f1a65cebff0c0cb",
      "line": 211,
      "relation": "decreases",
      "source": 19,
      "target": 31,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "009b4e032f8152de45c5db643d155339",
      "line": 176,
      "relation": "decreases",
      "source": 18,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "4e060d35701519ff8637b1139cb9d507",
      "line": 212,
      "relation": "decreases",
      "source": 18,
      "target": 40,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "1190881b515e9242d705770238860f42",
      "line": 177,
      "relation": "decreases",
      "source": 27,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "4e63d4d1a0f0eb6a09fdb46f99fb05f4",
      "line": 213,
      "relation": "association",
      "source": 27,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "c48063f664cf9c08df76e33773ed658b",
      "line": 214,
      "relation": "association",
      "source": 27,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "048dd2b16e07832e8dfb133f2b067ce3",
      "line": 178,
      "relation": "decreases",
      "source": 13,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "2fe3c96472fae19095874fddde796e19",
      "line": 215,
      "relation": "association",
      "source": 13,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "15e3c37f3fe3a399e133db5593a24872",
      "line": 179,
      "relation": "decreases",
      "source": 6,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "596d0e15ac1f24ec1359a669cedd201c",
      "line": 216,
      "relation": "association",
      "source": 6,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "daa1a83aceb832956244fa5dc6f08c25",
      "line": 217,
      "relation": "association",
      "source": 6,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "fb7d6c6c08969a33bbfa775a6abe21ad",
      "line": 180,
      "relation": "decreases",
      "source": 2,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "f2a23819b7b15df9f2c7174948442994",
      "line": 218,
      "relation": "decreases",
      "source": 2,
      "target": 31,
      "target_modifier": {
        "modifier": "Activity"
      }
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "56a0eb4943f1199f68105a54f5a0699e",
      "line": 181,
      "relation": "decreases",
      "source": 22,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "e0ef3c34e0aa0f6fcc95bf3995db926a",
      "line": 219,
      "relation": "association",
      "source": 22,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "4f9f3951f7873ec069daf24dff2800c2",
      "line": 182,
      "relation": "decreases",
      "source": 1,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "385fa4751ed02187147a0fa36088f207",
      "line": 220,
      "relation": "association",
      "source": 1,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "8fd69782932b0dbd6db1d3118a34d723",
      "line": 183,
      "relation": "decreases",
      "source": 17,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "0f1191d32a445ed0af47021a43212921",
      "line": 221,
      "relation": "association",
      "source": 17,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "8c6b7c4cf90378d22a7e6f9da1712196",
      "line": 222,
      "relation": "association",
      "source": 17,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "9e16df793ed05279922a5b72897e3b49",
      "line": 186,
      "relation": "association",
      "source": 48,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "52f24d9b70abfb0d5762af0cd8b60f74",
      "line": 187,
      "relation": "association",
      "source": 49,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "9927d5562ff104333a8007b7a617f3cd",
      "line": 188,
      "relation": "association",
      "source": 32,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "f175e6d3d75a14074dc28c311e2f7d79",
      "line": 198,
      "relation": "association",
      "source": 32,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "82a9254b5704dd12c79a6d747df7fd5e",
      "line": 189,
      "relation": "association",
      "source": 33,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "6307d807e8298eff94ecd6ee9ebfbd66",
      "line": 190,
      "relation": "association",
      "source": 42,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "0bbebf1726527957dc4b8d89278763c1",
      "line": 191,
      "relation": "association",
      "source": 43,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "925e029007d5ba036448bc175a57fd4a",
      "line": 192,
      "relation": "association",
      "source": 35,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "7f3d8d8720acf35b3eec598122f81d05",
      "line": 193,
      "relation": "association",
      "source": 37,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "139a087bad3bb6faa8527f9946c90ee9",
      "line": 194,
      "relation": "association",
      "source": 34,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "5f36c99c6f763101e4e7a1ed24027365",
      "line": 195,
      "relation": "association",
      "source": 46,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "7714420fcc8d26f6863b68451b5d601d",
      "line": 196,
      "relation": "association",
      "source": 47,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "0a177815000aceec2bafc0069a8bee77",
      "line": 197,
      "relation": "association",
      "source": 55,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "e29194eaaa9cfc68e47423c6cec1ad2a",
      "line": 199,
      "relation": "association",
      "source": 61,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "22a43bfb545655a883426e81764cbd30",
      "line": 200,
      "relation": "association",
      "source": 50,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "688e74928fb35f7aa0d537dfb6c1c213",
      "line": 203,
      "relation": "association",
      "source": 57,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "d8331cdc8182b56737a170c15717d80c",
      "line": 215,
      "relation": "association",
      "source": 57,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "c261e7a9f535b2e0d773564305495eeb",
      "line": 216,
      "relation": "association",
      "source": 57,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ebb8ab2c5a5058a18c974b2d069daf9c",
      "line": 205,
      "relation": "association",
      "source": 38,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "b61d58dc036f3c26ae3172ddb5ce3fcc",
      "line": 219,
      "relation": "association",
      "source": 41,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "d8083c2379f6e2e93883bd2e3825ed43",
      "line": 210,
      "relation": "association",
      "source": 59,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "77c920fecef3a3cd31aa7897ef312234",
      "line": 213,
      "relation": "association",
      "source": 56,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "441604e3a1ada3a2cf35370239483580",
      "line": 214,
      "relation": "association",
      "source": 51,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "d5c142a2cad82d5228d0167387bf1775",
      "line": 217,
      "relation": "association",
      "source": 58,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "6616255428678dc89a012d93c2962274",
      "line": 221,
      "relation": "association",
      "source": 53,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "identifier": "30640040",
        "journal": "Neurobiology of aging",
        "last": "Mandelkow E",
        "name": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "namespace": "pubmed",
        "pages": "24-34",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "b35b1107100ec6f74fb8bd9497d612f7",
      "line": 222,
      "relation": "association",
      "source": 45,
      "target": 17
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "8e1da50e6008ffdd1b37825776666311"
    },
    {
      "bel": "a(PUBCHEM:10341154)",
      "concept": {
        "name": "10341154",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "d0fba515a5cdcc6c6b25a6be4b4dc2aa"
    },
    {
      "bel": "a(PUBCHEM:10435235)",
      "concept": {
        "name": "10435235",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "6188759816635812ddd8bbfb29a90939"
    },
    {
      "bel": "a(PUBCHEM:11154925)",
      "concept": {
        "name": "11154925",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "dcd69f909c2caa397af38cd2c003ca9d"
    },
    {
      "bel": "a(PUBCHEM:11234052)",
      "concept": {
        "name": "11234052",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "55e3310d76f2369e9c85abbf3edd946c"
    },
    {
      "bel": "a(PUBCHEM:11570805)",
      "concept": {
        "name": "11570805",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "d65778253b00f63e246e12ba140471bb"
    },
    {
      "bel": "a(PUBCHEM:11655119)",
      "concept": {
        "name": "11655119",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "2c765465ba289258a2d4bb6e8e69ce35"
    },
    {
      "bel": "a(PUBCHEM:156422)",
      "concept": {
        "name": "156422",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "d1ff32597f575c90f2a31e80f14051e0"
    },
    {
      "bel": "a(PUBCHEM:24756910)",
      "concept": {
        "name": "24756910",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "a83b63e88127e8e42e148c24b4343060"
    },
    {
      "bel": "a(PUBCHEM:2746)",
      "concept": {
        "name": "2746",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "101d131bccb94defe4feb3898a2fb116"
    },
    {
      "bel": "a(PUBCHEM:3033825)",
      "concept": {
        "name": "3033825",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "c7d8d38a9680c9e7082cecdec4b56121"
    },
    {
      "bel": "a(PUBCHEM:4261)",
      "concept": {
        "name": "4261",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "e95d9dea4107a7117cca633e747edc5d"
    },
    {
      "bel": "a(PUBCHEM:42640)",
      "concept": {
        "name": "42640",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "11c7a1dc3557f145b9fcf1ee315f0492"
    },
    {
      "bel": "a(PUBCHEM:447966)",
      "concept": {
        "name": "447966",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "c6aa01fc53eefe17ac710e1942d17695"
    },
    {
      "bel": "a(PUBCHEM:448537)",
      "concept": {
        "name": "448537",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "36b2d27d6ed1a1eb6aa303aa525a2d1b"
    },
    {
      "bel": "a(PUBCHEM:4521392)",
      "concept": {
        "name": "4521392",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "91581207d8153b4acbcd3ead66a6c357"
    },
    {
      "bel": "a(PUBCHEM:46209426)",
      "concept": {
        "name": "46209426",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "e389087635e6afe7da116d96de75a983"
    },
    {
      "bel": "a(PUBCHEM:4878)",
      "concept": {
        "name": "4878",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "4cee0d2b53f75fee3e610b077b94ff8b"
    },
    {
      "bel": "a(PUBCHEM:49806720)",
      "concept": {
        "name": "49806720",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "977fa9bbe7189881a6167d1724d649a2"
    },
    {
      "bel": "a(PUBCHEM:5311272)",
      "concept": {
        "name": "5311272",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "f1fa6a8751d05a83c607700e83788785"
    },
    {
      "bel": "a(PUBCHEM:5318517)",
      "concept": {
        "name": "5318517",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "ae387b4ff83579135438b9213e3ee085"
    },
    {
      "bel": "a(PUBCHEM:53340666)",
      "concept": {
        "name": "53340666",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "e6ef205ddc0f44f5c05a490db98b7877"
    },
    {
      "bel": "a(PUBCHEM:5833)",
      "concept": {
        "name": "5833",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "da2bb427aaf1dcc180081924c5d408d0"
    },
    {
      "bel": "a(PUBCHEM:6321424)",
      "concept": {
        "name": "6321424",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "99bf5d596145f7f183a5cf8f8466d628"
    },
    {
      "bel": "a(PUBCHEM:71295844)",
      "concept": {
        "name": "71295844",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "748f5753b45c067662450ed2cf95082d"
    },
    {
      "bel": "a(PUBCHEM:71729974)",
      "concept": {
        "name": "71729974",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "fb83bb209dc48d54aa1d307fd9f23ab9"
    },
    {
      "bel": "a(PUBCHEM:9804992)",
      "concept": {
        "name": "9804992",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "10e0e7a1d8525e1731e1356a59ae1593"
    },
    {
      "bel": "a(PUBCHEM:9839311)",
      "concept": {
        "name": "9839311",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "043974014b140841790833d2aa67c951"
    },
    {
      "bel": "a(PUBCHEM:9865515)",
      "concept": {
        "name": "9865515",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "80927084ea2db167556719a4b92f612e"
    },
    {
      "bel": "a(PUBCHEM:9880)",
      "concept": {
        "name": "9880",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "0bab63a21192a0f8887fdfc8b96515b2"
    },
    {
      "bel": "bp(GO:\"cell killing\")",
      "concept": {
        "name": "cell killing",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d90ff2c504ac299738430c46896fc145"
    },
    {
      "bel": "p(FPLX:\"Gamma_secretase\")",
      "concept": {
        "name": "Gamma_secretase",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "e5aa42b4d5a7992fe30ecc5d01ae8dd8"
    },
    {
      "bel": "p(FPLX:\"HDAC_I\")",
      "concept": {
        "name": "HDAC_I",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "497b082718e3891c6c509c6a69c1992e"
    },
    {
      "bel": "p(FPLX:\"HDAC_II\")",
      "concept": {
        "name": "HDAC_II",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "a754e80a88a77ed8f0f9e09731677f09"
    },
    {
      "bel": "p(FPLX:Actin)",
      "concept": {
        "name": "Actin",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "70ff384ccc4427957df27ce1bb143da2"
    },
    {
      "bel": "p(FPLX:ESR)",
      "concept": {
        "name": "ESR",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "65e8f284f18d8ce1fd9eeae0e32eac2d"
    },
    {
      "bel": "p(FPLX:HDAC)",
      "concept": {
        "name": "HDAC",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "4963df953f4eaae0ba29f11bb988ab46"
    },
    {
      "bel": "p(FPLX:NFkappaB)",
      "concept": {
        "name": "NFkappaB",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "dafcbe06460fc2e93f4daf2113f37665"
    },
    {
      "bel": "p(FPLX:ROCK)",
      "concept": {
        "name": "ROCK",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "af4d155ac5c90c390760f1f4b7c7e420"
    },
    {
      "bel": "p(FPLX:TGFB)",
      "concept": {
        "name": "TGFB",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "911d7f50790453a94784d76bbeb4334a"
    },
    {
      "bel": "p(HGNC:ALK)",
      "concept": {
        "name": "ALK",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "798f3a64e529ffc86cdc2b4d2e11b325"
    },
    {
      "bel": "p(HGNC:AR)",
      "concept": {
        "name": "AR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4545a9fd93117463d368654c0cd789e3"
    },
    {
      "bel": "p(HGNC:EGFR)",
      "concept": {
        "name": "EGFR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2d0e5630f4a3b7a0fee65dbf00da20a5"
    },
    {
      "bel": "p(HGNC:ERBB2)",
      "concept": {
        "name": "ERBB2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c5005a7bea6e8529684cdb8190000be3"
    },
    {
      "bel": "p(HGNC:FLT1)",
      "concept": {
        "name": "FLT1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1e6f3f083b518598c191cce4942fd1b2"
    },
    {
      "bel": "p(HGNC:FYN)",
      "concept": {
        "name": "FYN",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9aaa70667f9bfd5fd59c45422ea4c02c"
    },
    {
      "bel": "p(HGNC:GSK3A)",
      "concept": {
        "name": "GSK3A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ce7c231328d7b0e85ffd798a554023bd"
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "concept": {
        "name": "GSK3B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8eaf29c9e491ff4e49619e77de92467c"
    },
    {
      "bel": "p(HGNC:HDAC1)",
      "concept": {
        "name": "HDAC1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "19e404c8c36931beb148345f3dae3052"
    },
    {
      "bel": "p(HGNC:HDAC3)",
      "concept": {
        "name": "HDAC3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2295758c8fd9e24078f3eb3e9fc6feea"
    },
    {
      "bel": "p(HGNC:HDAC6)",
      "concept": {
        "name": "HDAC6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8f10ead99d8970092c3980eb37bcfb3a"
    },
    {
      "bel": "p(HGNC:ICAM1)",
      "concept": {
        "name": "ICAM1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7f17c7170f0c093409f8f0505f248b50"
    },
    {
      "bel": "p(HGNC:KDR)",
      "concept": {
        "name": "KDR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "dfadabebebc33f282a378ff9219fef94"
    },
    {
      "bel": "p(HGNC:LCK)",
      "concept": {
        "name": "LCK",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b12ffdabce4924617b183ab3df9c996f"
    },
    {
      "bel": "p(HGNC:MAPK14)",
      "concept": {
        "name": "MAPK14",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0c0476ae2f3918834fb6ae31829c9b8d"
    },
    {
      "bel": "p(HGNC:MDM4)",
      "concept": {
        "name": "MDM4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6ea70fc64d3e53bf69ff54e5f02d6545"
    },
    {
      "bel": "p(HGNC:SELE)",
      "concept": {
        "name": "SELE",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "33877b8a1a5bf4e57583ada4781fba7d"
    },
    {
      "bel": "p(HGNC:TGFBR1)",
      "concept": {
        "name": "TGFBR1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "54347535ff7c9720f25fada9dbfb5f85"
    },
    {
      "bel": "p(HGNC:TGFBR2)",
      "concept": {
        "name": "TGFBR2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ecd80a47667baacbf3c5ab47563af97c"
    },
    {
      "bel": "p(HGNC:TNC)",
      "concept": {
        "name": "TNC",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e297c62c060fa85f68c8de931771a5a0"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Chloride channel accessory\")",
      "concept": {
        "name": "Chloride channel accessory",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "b92ef7958f55060b170f3c5bf92f7b4e"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Lysine demethylases\")",
      "concept": {
        "name": "Lysine demethylases",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "96f55d31441380a3a009df4861baa889"
    }
  ]
}